In a report released on January 15, Nik Modi from RBC Capital maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a ...
Colgate-Palmolive Co (CL) stock saw a modest uptick, ending the day at $88.56 which represents a slight increase of $0.70 or 0.80% from the prior close of $87.86. The stock opened at $87.6 and touched ...
Stifel highlighted that Colgate's Hill's pet nutrition brand continues to be a strong growth driver for the company. In the fourth quarter of 2024, Hill's achieved a remarkable 25% growth, with the ...
Zacks.com on MSN20h
Colgate Advances 13% in a Year: To Buy or Not to Buy the Stock?Colgate-Palmolive Company CL shares have appreciated 13.1% in the trailing 12 months, outperforming the Zacks Consumer ...
Stifel Nicolaus analyst Mark Astrachan maintained a Hold rating on Colgate-Palmolive (CL – Research Report) today and set a price target of ...
Colgate plays the Lafayette Leopards after Morgan McMahon scored 20 points in Colgate's 62-54 win over the Navy Midshipmen.
BSM Partners, the largest full-service pet care research, consulting, and strategy-to-shelf product innovation firm, is ...
Pallas Capital Advisors LLC lowered its position in Colgate-Palmolive (NYSE:CL – Free Report) by 6.6% in the 4th quarter, ...
Colgate-Palmolive Co (CL) stock saw a modest uptick, ending the day at $87.67 which represents a slight increase of $0.57 or 0.65% from the prior close of $87.1. The stock opened at $87.21 and touched ...
Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our ...
Six class action complaints accuse major dental product makers of deceptively marketing products containing fluoride to young ...
There is more to the comparison, and in the sections below, we discuss why we think CL will outperform KMB in the next three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback